Anson Funds Management LP - ORION BIOTECH OPPORTUNTES CO ownership

ORION BIOTECH OPPORTUNTES CO's ticker is and the CUSIP is G6780C109. A total of 28 filers reported holding ORION BIOTECH OPPORTUNTES CO in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Anson Funds Management LP ownership history of ORION BIOTECH OPPORTUNTES CO
ValueSharesWeighting
Q3 2022$738,000
+1.1%
75,0000.0%0.09%
+27.9%
Q2 2022$730,000
-0.1%
75,0000.0%0.07%
+15.3%
Q1 2022$731,000
+0.8%
75,0000.0%0.06%
-16.9%
Q4 2021$725,000
-1.6%
75,0000.0%0.07%
+1.4%
Q3 2021$737,00075,0000.07%
Other shareholders
ORION BIOTECH OPPORTUNTES CO shareholders Q3 2021
NameSharesValueWeighting ↓
Arena Capital Advisors, LLC- CA 141,317$1,448,4992.02%
Atalaya Capital Management LP 500,000$5,115,0001.63%
MMCAP International Inc. SPC 800,000$8,184,0001.61%
ANGELO GORDON & CO., L.P. 300,000$3,069,0000.77%
FIR TREE CAPITAL MANAGEMENT LP 792,269$8,104,9120.64%
Castle Creek Arbitrage, LLC 530,000$5,421,9000.60%
683 Capital Management, LLC 699,000$7,150,7700.53%
GLAZER CAPITAL, LLC 850,590$8,7020.48%
P SCHOENFELD ASSET MANAGEMENT LP 500,000$5,125,0000.45%
METEORA CAPITAL, LLC 366,183$3,746,0520.44%
View complete list of ORION BIOTECH OPPORTUNTES CO shareholders